Literature DB >> 17392113

The reparative effects of Momordica Charantia Linn. extract on HIT-T15 pancreatic beta-cells.

Leiwen Xiang1, Xiaonan Huang, Liumei Chen, Pingfan Rao, Lijing Ke.   

Abstract

The aim of this study is to investigate the cell reparative effects of Mormordical Charantia Linn. boiling water extract (MCE) on the HIT-T15 Hamster Pancreatic beta-cells. Furthermore, the superoxide dismutase (SOD) activity of MCE was determined. 0.02% MCE (w/v) achieved the highest cell proliferation rate of 45.6% (p<0.01) on alloxan damaged HIT-T15 cells while 0.2% MCE increased the proliferation of the normal cells by 35.4% (p<0.05). The high molecular weight fraction of MCE (MHMF, MW>3 kDa) showed the stronger effects in repairing alloxan damaged cells (cell proliferation rate=32.1%, p<0.05) than that of the low molecular weight fraction (MLMF, MW< or =3 kDa), while the latter showed the higher activity on increasing insulin secretion of normal or damaged cells. 2%MCE and MLMF showed the highest SOD activities, 19.74 NU/mL and 19.84 NU/mL, but they failed to improve the proliferation rate of alloxan damaged cells. These results indicated MCE has significant repairing effects on HIT-T15 cells against superoxide anion radicals, which did not correlate to MCEfs SOD activity. It was hypothesized that the different fractions of MCE may make different contributions to MCE's cell repairing activity and its ability of stimulating insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392113

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  9 in total

Review 1.  Effective components of Chinese herbal compound decoction and Maillard reaction.

Authors:  Zhi-yun Cao; Xu-zheng Chen; En-ta Chang; Jian Du
Journal:  Chin J Integr Med       Date:  2009-07-02       Impact factor: 1.978

2.  The effect of Momordica charantia intake on the estrogen receptors ESRα/ESRβ gene levels and apoptosis on uterine tissue in ovariectomy rats.

Authors:  Ozge Cevik; Hikmet Akpinar; Rabia Oba; Ozlem Tugce Cilingir; Zarife Nigar Ozdemir; Sule Cetinel; Tevfik Yoldemir
Journal:  Mol Biol Rep       Date:  2014-09-25       Impact factor: 2.316

Review 3.  Bitter melon: a panacea for inflammation and cancer.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Subhash B Padhye; Shrikant Anant
Journal:  Chin J Nat Med       Date:  2016-02

4.  Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.

Authors:  Amy C Keller; Jun Ma; Adam Kavalier; Kan He; Anne-Marie B Brillantes; Edward J Kennelly
Journal:  Phytomedicine       Date:  2011-11-30       Impact factor: 5.340

5.  The antioxidant effect of the Malaysian Gelam honey on pancreatic hamster cells cultured under hyperglycemic conditions.

Authors:  Kalaivani Batumalaie; Rajes Qvist; Kamaruddin Mohd Yusof; Ikram Shah Ismail; Shamala Devi Sekaran
Journal:  Clin Exp Med       Date:  2013-04-13       Impact factor: 3.984

Review 6.  Recent Advances in Momordica charantia: Functional Components and Biological Activities.

Authors:  Shuo Jia; Mingyue Shen; Fan Zhang; Jianhua Xie
Journal:  Int J Mol Sci       Date:  2017-11-28       Impact factor: 5.923

7.  Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment.

Authors:  Farhan Saeed; M Tauseef Sultan; Ayesha Riaz; Sagheer Ahmed; Nicusor Bigiu; Ryszard Amarowicz; Rosana Manea
Journal:  Plants (Basel)       Date:  2021-04-08

Review 8.  Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes.

Authors:  Yoon Sin Oh
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-26       Impact factor: 2.629

9.  In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd).

Authors:  Zuraini Ahmad; Khairul Faizi Zamhuri; Azhar Yaacob; Chiong Hoe Siong; Malarvili Selvarajah; Amin Ismail; Muhammad Nazrul Hakim
Journal:  Molecules       Date:  2012-08-10       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.